- Home
- FGEN vs IPWR Comparison
FGEN vs IPWR Comparison
Compare FGEN & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- IPWR
- Stock Information
- Founded
- FGEN 1993
- IPWR 2007
- Country
- FGEN United States
- IPWR United States
- Employees
- FGEN N/A
- IPWR N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- IPWR Industrial Machinery/Components
- Sector
- FGEN Health Care
- IPWR Industrials
- Exchange
- FGEN Nasdaq
- IPWR Nasdaq
- Market Cap
- FGEN 45.0M
- IPWR 52.8M
- IPO Year
- FGEN 2014
- IPWR 2013
- Fundamental
- Price
- FGEN $11.16
- IPWR $5.19
- Analyst Decision
- FGEN Strong Buy
- IPWR Hold
- Analyst Count
- FGEN 2
- IPWR 1
- Target Price
- FGEN $146.50
- IPWR N/A
- AVG Volume (30 Days)
- FGEN 30.7K
- IPWR 58.2K
- Earning Date
- FGEN 11-11-2025
- IPWR 11-13-2025
- Dividend Yield
- FGEN N/A
- IPWR N/A
- EPS Growth
- FGEN N/A
- IPWR N/A
- EPS
- FGEN N/A
- IPWR N/A
- Revenue
- FGEN $7,346,000.00
- IPWR $19,240.00
- Revenue This Year
- FGEN N/A
- IPWR N/A
- Revenue Next Year
- FGEN N/A
- IPWR $9,900.00
- P/E Ratio
- FGEN N/A
- IPWR N/A
- Revenue Growth
- FGEN N/A
- IPWR N/A
- 52 Week Low
- FGEN $4.50
- IPWR $3.77
- 52 Week High
- FGEN $21.94
- IPWR $8.62
- Technical
- Relative Strength Index (RSI)
- FGEN 46.07
- IPWR 48.87
- Support Level
- FGEN $11.36
- IPWR $4.74
- Resistance Level
- FGEN $12.13
- IPWR $5.58
- Average True Range (ATR)
- FGEN 0.54
- IPWR 0.53
- MACD
- FGEN -0.20
- IPWR -0.03
- Stochastic Oscillator
- FGEN 8.97
- IPWR 20.83
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About IPWR Ideal Power Inc.
Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.